Ligand validation:6ALN

ZZU: (2S,3S)-3-HYDROXYARGININE

ZZU is a Ligand Of Interest in 6ALN designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ALN_ZZU_A_403	75%	61%	0.112	0.944	0.82	0.68	-	-	0	0	100%	1
6ALP_ZZU_A_403	48%	63%	0.135	0.876	0.79	0.62	-	-	0	0	100%	1
2WBP_ZZU_A_1359	25%	28%	0.207	0.84	1.04	1.83	1	2	3	0	100%	0.7
2WBQ_ZZU_A_1358	21%	47%	0.202	0.812	0.84	1.18	-	1	0	0	100%	0.4
6Y12_ZZU_A_403	2%	19%	0.294	0.568	1.93	1.54	2	1	1	0	100%	0.7
4NE0_ZZU_C_403	66%	24%	0.127	0.932	1.07	2.03	-	1	1	0	100%	1
4M26_ZZU_C_403	56%	43%	0.152	0.923	1.01	1.18	-	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.